214 related articles for article (PubMed ID: 14736838)
21. Pediatric and adolescent lymphoma: comparison of whole-body STIR half-Fourier RARE MR imaging with an enhanced PET/CT reference for initial staging.
Punwani S; Taylor SA; Bainbridge A; Prakash V; Bandula S; De Vita E; Olsen OE; Hain SF; Stevens N; Daw S; Shankar A; Bomanji JB; Humphries PD
Radiology; 2010 Apr; 255(1):182-90. PubMed ID: 20308456
[TBL] [Abstract][Full Text] [Related]
22. PET/CT today and tomorrow.
Townsend DW; Carney JP; Yap JT; Hall NC
J Nucl Med; 2004 Jan; 45 Suppl 1():4S-14S. PubMed ID: 14736831
[TBL] [Abstract][Full Text] [Related]
23. PET in oncology: will it replace the other modalities?
Hoh CK; Schiepers C; Seltzer MA; Gambhir SS; Silverman DH; Czernin J; Maddahi J; Phelps ME
Semin Nucl Med; 1997 Apr; 27(2):94-106. PubMed ID: 9144854
[TBL] [Abstract][Full Text] [Related]
24. Positron emission tomography imaging in melanoma and lymphoma.
Abella-Columna E; Valk PE
Semin Roentgenol; 2002 Apr; 37(2):129-39. PubMed ID: 12134366
[No Abstract] [Full Text] [Related]
25. Is 18F-FDG PET more accurate than standard diagnostic procedures in the detection of suspected recurrent melanoma?
Fuster D; Chiang S; Johnson G; Schuchter LM; Zhuang H; Alavi A
J Nucl Med; 2004 Aug; 45(8):1323-7. PubMed ID: 15299056
[TBL] [Abstract][Full Text] [Related]
26. Oncological applications of FDG PET imaging: brain tumors, colorectal cancer, lymphoma and melanoma.
Delbeke D
J Nucl Med; 1999 Apr; 40(4):591-603. PubMed ID: 10210218
[TBL] [Abstract][Full Text] [Related]
27. PET/CT: a new imaging technology in nuclear medicine.
Schöder H; Erdi YE; Larson SM; Yeung HW
Eur J Nucl Med Mol Imaging; 2003 Oct; 30(10):1419-37. PubMed ID: 12961037
[TBL] [Abstract][Full Text] [Related]
28. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?
Casneuf V; Delrue L; Kelles A; Van Damme N; Van Huysse J; Berrevoet F; De Vos M; Duyck P; Peeters M
Acta Gastroenterol Belg; 2007; 70(4):331-8. PubMed ID: 18330088
[TBL] [Abstract][Full Text] [Related]
29. Molecular positron emission tomography and PET/CT imaging in urological malignancies.
Powles T; Murray I; Brock C; Oliver T; Avril N
Eur Urol; 2007 Jun; 51(6):1511-20; discussion 1520-1. PubMed ID: 17275167
[TBL] [Abstract][Full Text] [Related]
30. Integrating PET and PET/CT into the risk-adapted therapy of lymphoma.
Kasamon YL; Jones RJ; Wahl RL
J Nucl Med; 2007 Jan; 48 Suppl 1():19S-27S. PubMed ID: 17204717
[TBL] [Abstract][Full Text] [Related]
31. PET/CT scanners: a hardware approach to image fusion.
Townsend DW; Beyer T; Blodgett TM
Semin Nucl Med; 2003 Jul; 33(3):193-204. PubMed ID: 12931321
[TBL] [Abstract][Full Text] [Related]
32. Why most PET of lung and head-and-neck cancer will be PET/CT.
Goerres GW; von Schulthess GK; Steinert HC
J Nucl Med; 2004 Jan; 45 Suppl 1():66S-71S. PubMed ID: 14736837
[TBL] [Abstract][Full Text] [Related]
33. Automated 3-dimensional registration of stand-alone (18)F-FDG whole-body PET with CT.
Slomka PJ; Dey D; Przetak C; Aladl UE; Baum RP
J Nucl Med; 2003 Jul; 44(7):1156-67. PubMed ID: 12843232
[TBL] [Abstract][Full Text] [Related]
34. PET/CT image navigation and communication.
Ratib O
J Nucl Med; 2004 Jan; 45 Suppl 1():46S-55S. PubMed ID: 14736835
[TBL] [Abstract][Full Text] [Related]
35. Impact of technology on the utilisation of positron emission tomography in lymphoma: current and future perspectives.
Visvikis D; Ell PJ
Eur J Nucl Med Mol Imaging; 2003 Jun; 30 Suppl 1():S106-16. PubMed ID: 12748830
[TBL] [Abstract][Full Text] [Related]
36. 18F-FDG PET/CT delayed images after diuretic for restaging invasive bladder cancer.
Anjos DA; Etchebehere EC; Ramos CD; Santos AO; Albertotti C; Camargo EE
J Nucl Med; 2007 May; 48(5):764-70. PubMed ID: 17475965
[TBL] [Abstract][Full Text] [Related]
37. X-ray-based attenuation correction for positron emission tomography/computed tomography scanners.
Kinahan PE; Hasegawa BH; Beyer T
Semin Nucl Med; 2003 Jul; 33(3):166-79. PubMed ID: 12931319
[TBL] [Abstract][Full Text] [Related]
38. The role of 18F-FDG PET/CT for initial staging of nasal type natural killer/T-cell lymphoma: a comparison with conventional staging methods.
Moon SH; Cho SK; Kim WS; Kim SJ; Chan Ahn Y; Choe YS; Lee KH; Kim BT; Choi JY
J Nucl Med; 2013 Jul; 54(7):1039-44. PubMed ID: 23658217
[TBL] [Abstract][Full Text] [Related]
39. PET/CT: panacea, redundancy, or something in between?
Vogel WV; Oyen WJ; Barentsz JO; Kaanders JH; Corstens FH
J Nucl Med; 2004 Jan; 45 Suppl 1():15S-24S. PubMed ID: 14736832
[TBL] [Abstract][Full Text] [Related]
40. PET/CT in diagnostic oncology.
Messa C; Bettinardi V; Picchio M; Pelosi E; Landoni C; Gianolli L; Gilardi MC; Fazio F
Q J Nucl Med Mol Imaging; 2004 Jun; 48(2):66-75. PubMed ID: 15243404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
